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Recurrent goiter and amenorrhea-galactorrhea 
Syndrome in a patient with a thyrotropin (TSH) 
and prolactin (PRL) producing pituitary 
adenoma 
K . H O R N , R. F A H L B U S C H , U . H A C H M E I S T E R , C R . P I C K A R D T , K . V O N W E R D E R 
and P.C. S C R I B A 
M e d i c a l C l i n i c II, University o f M u n i c h , F e d e r a l Republic o f Germany 
The pathophysiological mechanisms of the simultaneous hypersecretion of T S H and P R L 
due to a pituitary adenoma are discussed on the basis of one very unusual patient. 
C A S E H I S T O R Y 
In 1968 the female patient suffered from rapid goitral growth and clinical signs of 
hyperthyroidism. In 1969 the first resection of the goiter was performed, mainly because 
of tracheal compression. Two years later, she complained of recurrent goiter with Stridor 
and dyspnea. Therefore, in 1971 thyroid surgery with plastic reconstruction of the tra-
chea had to be performed. In 1972, at the age of 20 years, she was admitted to hospital 
because of a third period of goitral growth despite prophylactic thyroid hormone thera-
py. A t this time amenorrhea and galactorrhea became apparent. 
R E S U L T S A N D D I S C U S S I O N 
On admission the levels of T4 (10.8 /ig%), of T3 (189 ng%) and of the R T 3 U (43%) were 
slightly elevated (normal ranges: T4 = 4.5-10.0 jug%; T3 = 80-150 ng%; R T 3 U = 32-42%). 
The basal T S H level was elevated (23 juU/ml; normal ränge: 0.4-3.8 p.U/ml). The basal 
P R L level was grossly increased up to 4800 juU/ml, corresponding to 240 ng V L S Standard/ 
ml (normal ränge in females: 150-650 / i U R S A 71/222/ml). 
The history and the findings indicated a hormonally active anterior pituitary tumor. 
The sella turcica was enlarged, but visual fields were normal. Other pituitary functions 
were not impaired, as shown by a normal rise of growth hormone and cortisol during the 
insulin hypoglycemia test and of L H and F S H after application of 25 /ig L R F . 
In healthy subjects T S H and P R L increase after T R H Stimulation (normal ranges after 
200 /ig T R H i . V . ; A T S H 30 min: 2.7-23.6 / i U / m l ; A P R L 20 min: 500-1700 / iU /ml ) . The 
T S H and P R L responses to T R H are suppressed (TSH) or diminished ( P R L ) in hyperthy-
roidism, but increased in hypothyroidism. In this patient, the rise of the elevated basal 
T S H and P R L levels after T R H Stimulation were inadequate (A T S H 30 min: 0.5 /zU/ml ; 
A P R L 20 min: 605 / i U / m l ) . Such impaired responsiveness of P R L to T R H has been 
demonstrated in patients with a prolactin-producing pituitary adenoma ( V o n Werder, 
1975). The non-suppressibility of T S H and P R L could be demonstrated by the appli-
cation of thyroid hormones up to 150 /zg T4 plus 30 / ig T3 which raised the T4 to 
16.2 /ig% and the T3 uptake to 52%. A disturbance of peripheral conversion of T4 to T3 
could be excluded, since the T3 level increased to 392 ng% (T4: 19.1 /ig%) after adminis-
tration of 300 /ig T4 per day. However, both T S H and P R L levels remained elevated, 
fluctuating between 13.6 and 2 5 . 6 / i U / m l (TSH), and between 3100 and 6 6 0 0 / i U / m l 
( P R L ) . This indicated that T S H and P R L could not be physiologically regulated by T R H 
and thyroid hormones. 
Pharmacological studies showed that both T S H and P R L levels could be lowered by 
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500 mg L-dopa with a nadir after 120 min. T S H decreased from 26.0 / i U / m l to 1 9 . 0 / i U / 
ml and P R L from 4400juU/ml to 1800juU/ml. As expected, 5 mg of bromocriptine 
decreased the P R L levels from 3100 to 7 4 0 / i U / m l and in parallel decreased the T S H 
levels from 11.9 to 6.4 /zU/ml with a nadir after 180 min. 
The unknown proliferative potency of T S H and P R L producing tumors prompted us 
to have this hormonally active tumor removed by transsphenoidal hypophysectomy and 
cryoresection of possible remnants of tumor tissue. This decreased T S H and P R L levels in 
parallel to unmeasurable values (Fig. 1). Today, the patient has panhypopituitarism, but 
she is fully active as a nurse under replacement therapy with cortisol, thyroxine and 
gonadal Steroids. 
T S H h P R L Curellpge Crjo 
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FIG. 1. Parallel decline of PRL 
and TSH d u r i n g and after trans-
sphenoidal surgery. 
Several possible pathophysiological mechanisms may explain the simultaneous hyper-
secretion o f TSH and P R L : 
1. Concomitant hypersecretion of P R L with T S H . In primary hypothyroidism, the elev-
ated T S H and P R L can be normalized by thyroid hormone therapy; this was not so in our 
patient. The development of TSH-producing tumors in rats can result from chronic hypo-
thyroidism. Analogous pituitary tumors in humans can occur in areas with severe iodine 
deficiency and cretinism (König, 1968). However, this explanation is not applicable to 
our patient, since hypothyroidism was never experienced. 
2. P R L hypersecretion due to a suprasellar extension of the TSH-producing tumor re-
sulting in PIF inhibition. Our patient had no ophthalmological, laboratory or pneumence-
phalographic signs of suprasellar extension. 
3. Autonomous T S H and P R L hypersecretion by the pituitary tumor. The inadequate 
increase of both T S H and P R L after T R H Stimulation and the lack of suppression by 
thyroid hormones indicated an autonomous hormone secretion. In addition electron-
microscopic and immunofluorescent findings revealed no signs of a diffuse hyperplasia of 
the pituitary gland, but instead two closely associated cell types were found throughout 
the adenoma, of which one was idcntified as lactotroph and the cther thyrotroph. 
4. Primary T R H hypersecretion leading to a hyperplasiogenic T S H and P R L producing 
pituitary adenoma. This is excludable only by measuring T R H in the portal vessels, 
something not feasible in humans. The results of long-term oral treatment with T R H 
argue against an endogenous T R H excess causing hyperthyroidism. Daily application of 
40 mg T R H orally over a period of 4 weeks diminished the T S H response after 200 jitg 
T R H i . V . , while the T4 and T3 levels were not increased (Table 1), whereas transitory 
increases of the thyroid hormone levels within the normal ränge after each oral applica-
tion of T R H occur more acutely (unpublished data). This indicates that the suppressive 
effect of thyroid hormones on T S H release overrules the stimulatory effect of T R H as 
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TABLE l Effect of oral TRH application to healthy subjects (N = 1 2 ; 4 0 mg per day over a period 
of 4 weeks) 
Before TRH After TRH 
40 mg per day 
Serum TSH Basal 2.0 ± 0.8 1.0 ± 0.5* 
(MÜ/ml) A T S H 3 Q ^ g { ± 3 Q 3 0 ± 
Serum T4 6.2 ± 1.9 6.5 ± 1.8 
(Mg/100 ml) 
Serum T3 112 ± 22 109 ± 32 
(ng/100 ml) 
* p < 0.005 
shown by repetitive i.v. administration of T R H (Snyder and Utiger, 1973). Thus endo-
genous T R H excess is unlikely to cause the hypersecretion of T S H and P R L , resulting in a 
toxic goiter and amenorrhea-galactorrhea Syndrome, as observed in this patient. 
In conclusion, the patient studied is the first presenting a pituitary adenoma with 
autonomous T S H and P R L hypersecretion. 
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